Rituximab May Benefit Patients with Refractory JIA-Associated Uveitis
![](https://fbexternal-a.akamaihd.net/safe_image.php?d=AQC4HAY5LvKKGGdN&w=470&h=246&url=http%3A%2F%2Fwww.the-rheumatologist.org%2Fwp-content%2Fthemes%2Fthr%2Fimages%2Fdefault-social-icon.png&cfs=1&upscale=1&ext=png2jpg)
NEW YORK (Reuters Health)—Rituximab may calm juvenile idiopathic arthritis (JIA)-associated uveitis and especially benefit patients who haven’t responded to…
www.the-rheumatologist.org
Adalimumab effective for Uveitis in Juvenile Idiopathic Arthritis patients
Drug Effective for JIA-Associated Eye Disease
![](https://fbexternal-a.akamaihd.net/safe_image.php?d=AQAjzFchwACSnQ6D&w=158&h=158&url=https%3A%2F%2Fs3.amazonaws.com%2Fhcplive%2Fv1_media%2F_conferences%2FACR_ARHP_2015_banner_728x90.jpg&cfs=1&upscale=1&ext=png2jpg)
A UK team reporting at the American College of Rheumatology Annual Meeting in San Francisco, CA said it found that adalimumab (Humira/AbbVie)…
www.hcplive.com